Clinical Trial Update: Comparison of Insulin Detemir Versus Insulin NPH on Weight Change in Overweight and Obese With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial comparing insulin detemir to insulin NPH in overweight/obese individuals with type 2 diabetes; results pertain to weight change.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin detemir (insulin detemir)
• insulin NPH (insulin NPH)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED